共 50 条
Measuring the cost-effectiveness of treating rectovaginal and vesicovaginal fistulas: A multicenter global study by the Fistula Foundation
被引:1
|作者:
Rajagopal, Keerthana
[1
,2
]
Pollaczek, Lindsey
[1
]
Chu, Jesse
[1
]
Mann, Hannah
[1
]
机构:
[1] Fistula Fdn, San Jose, CA USA
[2] Fistula Fdn, 1700 The Alameda 300, San Jose, CA 95126 USA
关键词:
cost-effectiveness;
disability-adjusted life-years;
rectovaginal fistula;
resource allocation;
vesicovaginal fistula;
OBSTETRIC FISTULA;
D O I:
10.1002/ijgo.15502
中图分类号:
R71 [妇产科学];
学科分类号:
100211 ;
摘要:
ObjectiveSurgery for obstetric fistula is a highly effective treatment to restore continence and improve quality of life. However, a lack of data on the cost-effectiveness of this procedure limits prioritization of this essential treatment. This study measures the effectiveness of fistula surgeries using disability-adjusted life years (DALYs) averted.MethodsIn 2021 and 2022, the Fistula Foundation funded 20 179 fistula surgeries and related procedures at 143 hospitals among 27 countries. We calculated DALYs averted specifically for vesicovaginal fistula and rectovaginal fistula procedure types (n = 13 235 surgeries) by using disability weights from the 2019 Global Burden of Disease study. We based cost calculations on direct treatment expenses, including medical supplies, health provider fees, and preoperative and postoperative care. We measured effectiveness using data on the risk of permanent disability, country-specific average life spans, and treatment outcomes.ResultsThe total treatment cost was $7.6 million, and a total of 131 433 DALYs were averted. Thus, the cost per DALY averted-the cost to restore 1 year of healthy life-was $58. For this analysis, we took a cautious approach and weighted only surgeries that resulted in a closed fistula with restored continence. We calculated DALYs averted by country. Limitations of the study include data entry errors inherent in patient logs and lack of long-term outcomes.ConclusionThe current study demonstrates that obstetric fistula surgery, along with having a significant positive impact on maternal health outcomes, is highly cost-effective in comparison with other interventions. The study therefore highlights the benefits of prioritizing fistula treatment as part of the global agenda for maternal health care. Obstetric fistula treatment is highly cost-effective. The current study highlights the benefits of prioritizing fistula treatment as part of the global agenda for maternal health care.
引用
收藏
页码:480 / 486
页数:7
相关论文